immunosuppression

(redirected from Immunosuppressive therapy)
Also found in: Thesaurus, Medical, Legal, Encyclopedia.
Related to Immunosuppressive therapy: Immunosuppressive medications

im·mu·no·sup·pres·sion

 (ĭm′yə-nō-sə-prĕsh′ən, ĭ-myo͞o′-)
n.
Suppression of the immune response, as by drugs or radiation, in order to prevent the rejection of grafts or transplants or to control autoimmune diseases. Also called immunodepression.

im′mu·no·sup·pres′sant (-prĕs′ənt) n.
im′mu·no·sup·pressed′ (-prĕst′) adj.
im′mu·no·sup·pres′sive adj.

immunosuppression

(ˌɪmjʊnəʊsəˈprɛʃən)
n
(Medicine) medical suppression of the body's immune system, esp in order to reduce the likelihood of rejection of a transplanted organ

im•mu•no•sup•pres•sion

(ˌɪm yə noʊ səˈprɛʃ ən, ɪˌmyu-)

n.
the inhibition of the normal immune response because of disease, the administration of drugs, or surgery.
[1960–65]
im`mu•no•sup•press′, v.t. -pressed, -press•ing.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.immunosuppression - lowering the body's normal immune response to invasion by foreign substances; can be deliberate (as in lowering the immune response to prevent rejection of a transplanted organ) or incidental (as a side effect of radiotherapy or chemotherapy for cancer)
immunological disorder - a disorder of the immune system
Translations

immunosuppression

[ɪˈmjʊːnəʊsəˈpreʃən] Ninmunosupresión f

immunosuppression

n inmunosupresión f
References in periodicals archive ?
Contract notice: Delivery dressings, drapes, immunosuppressive therapy and dialysis concentrates.
Persistent graft function in the device was demonstrated, with regulated insulin secretion and preservation of islet morphology and function without any immunosuppressive therapy.
Infection is frequent and the unusual spectrum of organisms is thought to be related to the combined effect of immune system anomalies and immunosuppressive therapy.
She was on immunosuppressive therapy but was human immunodeficiency virus (HIV)-negative.
All patients will also receive physical therapy post surgery, as well as immunosuppressive therapy, which will be for three months, as tolerated.
The likelihood of survival was not affected by the duration of natalizumab use or prior use of immunosuppressive therapy.
In spite of prophylactic measures and the use of wide-spectrum antibiotics, hospital-acquired pneumonia (HAP) is still an important cause of morbidity and mortality in patients receiving immunosuppressive therapy [1].
Some areas examined include costimulation blockade as a regulatory t- cell inducing therapy, strategies for T cell depletion to prevent graft versus host disease, leukocyte intracellular cytokines in lung transplant patients, indications and management of m-TOR inhibitors after liver transplantation, and the role of pharmacogenomics in tailoring immunosuppressive therapy for liver transplant recipients.
Doctors commonly prescribe a combination of cytotoxic drugs and glucocorticoids as immunosuppressive therapy to help recipients of transplants avoid rejection of their new organs, and patients with rheumatoid arthritis, asthma, and other conditions often take glucocorticoids.
Since the late 1980s, several reports have described a prolongation of time to transplantation through the administration of immunosuppressive therapy for patients diagnosed by endomyocardial biopsy.
The fibrocalcific nodules found on the chest radiograph imply that either 1) the patient might have had histoplasmosis for years and it became disseminated because of immunosuppressive therapy for rheumatoid arthritis or 2) the patient was reinfected with the calcified lesions that resulted from prior histoplasmosis.
Only physicians experienced in immunosuppressive therapy and management of renal, cardiac or hepatic transplant patients should use CellCept.